Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$34,446,853
-$3,515,305 QoQ
Shares Held
272,652
+0.1% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
2.40%
of 13F equity value
Holder Rank
#260
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. GILD ranks #3 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,446,853 | 272,652 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $37,962,158 | 272,384 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $33,337,165 | 271,608 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $30,047,589 | 270,699 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $31,462,466 | 283,778 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,704,218 | 327,570 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $34,925,281 | 378,102 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $30,797,031 | 367,331 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $23,718,133 | 345,695 | Shares | Sole | 2024-09-16 | |
| 2024-03-31 | $22,796,352 | 311,213 | Shares | Sole | 2024-09-16 | |
| 2023-12-31 | $27,749,651 | 342,546 | Shares | Sole | 2024-11-07 | |
| 2023-09-30 | $25,577,546 | 341,307 | Shares | Sole | 2024-11-07 | |
| 2023-06-30 | $25,986,154 | 337,176 | Shares | Sole | 2024-11-07 | |
| 2023-03-31 | $26,527,417 | 319,723 | Shares | Sole | 2024-11-07 | |
| 2022-12-31 | $27,130,059 | 316,017 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $19,715,938 | 319,597 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $19,138,724 | 309,638 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $18,586,507 | 312,641 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $15,246,357 | 209,976 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $14,313,871 | 204,923 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $13,489,054 | 195,891 | Shares | Sole | 2021-09-20 | |
| 2021-03-31 | $12,660,435 | 195,891 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $8,882,319 | 152,460 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $8,401,931 | 132,963 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,291,065 | 94,763 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $6,935,559 | 92,771 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||